It has been reported that a few regulatory factors associated with iron metabolism exhibits relevance to prostate cancer, including Hepcidin [6], redox-sensitive transcription factor (NF-κB) [7] and Ferroportin (FPN) [5]. Here, SLC40A1 is linked to prostate carcinoma.